CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net loss	$ (300,293)	$ (66,470)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and intangible asset amortization	489,024	495,878
Amortization of deferred subscriber acquisition costs	22,627	18,232
Amortization of deferred subscriber acquisition revenue	(29,477)	(24,339)
Share-based compensation expense	23,499	23,710
Deferred income taxes	(82,507)	(23,607)
Provision for losses on receivables and inventory	45,692	13,406
Loss on extinguishment of debt	65,843	21,561
Loss on sale of business	77	0
Gain (Loss) on Interest Rate Derivative Instruments Not Designated as Hedging Instruments	69,563	3,505
Other non-cash items, net	48,579	25,973
Changes in operating assets and liabilities, net of the effects of acquisitions:
Deferred subscriber acquisition costs	(48,194)	(45,953)
Deferred subscriber acquisition revenue	39,714	62,908
Other, net	(93,918)	4,458
Net cash provided by operating activities	250,229	509,262
Cash flows from investing activities:
Dealer generated customer accounts and bulk account purchases	(62,247)	(163,333)
Subscriber system assets	(64,830)	(144,888)
Capital expenditures	(34,571)	(37,707)
Acquisition of businesses, net of cash acquired	(179,569)	(53,893)
Other investing, net	2,782	(244)
Net cash used in investing activities	(338,435)	(400,065)
Cash flows from financing activities:
Proceeds from long-term borrowings	1,640,000	0
Repayment of long-term borrowings, including call premiums	(1,438,044)	(331,689)
Dividends on common stock	(26,291)	(26,481)
Repurchases of common stock	0	(21,854)
Deferred financing costs	(14,139)	(140)
Other financing, net	(3,915)	0
Net cash provided by (used in) financing activities	157,611	(380,164)
Effect of currency translation on cash	0	663
Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents	69,405	(270,304)
Cash and cash equivalents and restricted cash and cash equivalents at beginning of period	48,736	367,162
Cash and cash equivalents and restricted cash and cash equivalents at end of period	118,141	96,858
Supplemental schedule of non-cash investing and financing activities:
Issuance of shares in lieu of cash dividend	3	22,441
Issuance of shares for acquisition of business	$ 113,841	$ 0